Year |
Citation |
Score |
2015 |
Li Y, Li X, Sun WK, Cheng C, Chen YH, Zeng K, Chen X, Gu Y, Gao R, Liu R, Lu X. Comparison of liver microRNA transcriptomes of Tibetan and Yorkshire pigs by deep sequencing. Gene. PMID 26656174 DOI: 10.1016/j.gene.2015.12.003 |
0.364 |
|
2015 |
Liao WQ, Qi YL, Wang L, Dong XM, Xu T, Ding CD, Liu R, Liang WC, Lu LT, Li H, Li WF, Luo GB, Lu XC. Recql5 protects against lipopolysaccharide/D-galactosamine-induced liver injury in mice. World Journal of Gastroenterology : Wjg. 21: 10375-84. PMID 26420964 DOI: 10.3748/wjg.v21.i36.10375 |
0.362 |
|
2012 |
Bajo M, Madamba SG, Lu X, Sharkey LM, Bartfai T, Siggins GR. Receptor subtype-dependent galanin actions on gamma-aminobutyric acidergic neurotransmission and ethanol responses in the central amygdala. Addiction Biology. 17: 694-705. PMID 21955024 DOI: 10.1111/J.1369-1600.2011.00360.X |
0.316 |
|
2010 |
Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors, and drug targets. Experientia. Supplementum. 102: 7-23. PMID 21299058 DOI: 10.1007/978-3-0346-0228-0_2 |
0.349 |
|
2010 |
Lu X, Roberts E, Xia F, Sanchez-Alavez M, Liu T, Baldwin R, Wu S, Chang J, Wasterlain CG, Bartfai T. GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models. Proceedings of the National Academy of Sciences of the United States of America. 107: 15229-34. PMID 20660766 DOI: 10.1073/Pnas.1008986107 |
0.341 |
|
2009 |
Mitsukawa K, Lu X, Bartfai T. Bidirectional regulation of stress responses by galanin in mice: Involvement of galanin receptor subtype 1 Neuroscience. 160: 837-846. PMID 19272414 DOI: 10.1016/J.Neuroscience.2009.02.063 |
0.325 |
|
2009 |
Lu X, Bartfai T. Analyzing the validity of GalR1 and GalR2 antibodies using knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 379: 417-20. PMID 19159918 DOI: 10.1007/S00210-009-0394-Z |
0.359 |
|
2008 |
Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T. Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral tests. Neuropeptides. 42: 387-97. PMID 18554714 DOI: 10.1016/J.Npep.2008.04.009 |
0.314 |
|
2007 |
Lu X, Sharkey L, Bartfai T. The brain galanin receptors: targets for novel antidepressant drugs. Cns & Neurological Disorders Drug Targets. 6: 183-92. PMID 17511615 DOI: 10.2174/187152707780619335 |
0.365 |
|
2007 |
Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Molecular Psychiatry. 12: 167-89. PMID 17033635 DOI: 10.1038/Sj.Mp.4001897 |
0.313 |
|
2006 |
Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek J, Bartfai T. A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical tests. Neuroscience Letters. 405: 111-5. PMID 16854525 DOI: 10.1016/J.Neulet.2006.06.033 |
0.378 |
|
2006 |
Shi TJ, Hua XY, Lu X, Malkmus S, Kinney J, Holmberg K, Wirz S, Ceccatelli S, Yaksh T, Bartfai T, Hökfelt T. Sensory neuronal phenotype in galanin receptor 2 knockout mice: focus on dorsal root ganglion neurone development and pain behaviour. The European Journal of Neuroscience. 23: 627-36. PMID 16487144 DOI: 10.1111/J.1460-9568.2006.04593.X |
0.312 |
|
2005 |
Wirz SA, Davis CN, Lu X, Zal T, Bartfai T. Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides. 39: 535-46. PMID 16242774 DOI: 10.1016/J.Npep.2005.09.001 |
0.346 |
|
2005 |
Mazarati A, Lu X. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors. Neuropeptides. 39: 277-80. PMID 15944022 DOI: 10.1016/J.Npep.2004.12.003 |
0.379 |
|
2005 |
Lundström L, Lu X, Langel U, Bartfai T. Important pharmacophores for binding to galanin receptor 2. Neuropeptides. 39: 169-71. PMID 15944008 DOI: 10.1016/J.Npep.2004.12.029 |
0.331 |
|
2005 |
Lu X, Lundström L, Bartfai T. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes. Neuropeptides. 39: 165-7. PMID 15944007 DOI: 10.1016/J.Npep.2004.12.013 |
0.376 |
|
2005 |
Lu X, Mazarati A, Sanna P, Shinmei S, Bartfai T. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity. Neuropeptides. 39: 147-52. PMID 15944003 DOI: 10.1016/J.Npep.2004.12.011 |
0.403 |
|
2005 |
Lu X, Lundström L, Langel U, Bartfai T. Galanin receptor ligands. Neuropeptides. 39: 143-6. PMID 15944002 DOI: 10.1016/J.Npep.2004.12.012 |
0.372 |
|
2005 |
Badie-Mahdavi H, Lu X, Behrens MM, Bartfai T. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice. Neuroscience. 133: 591-604. PMID 15885916 DOI: 10.1016/J.Neuroscience.2005.02.042 |
0.364 |
|
2005 |
Jourdi H, Lu X, Yanagihara T, Lauterborn JC, Bi X, Gall CM, Baudry M. Prolonged positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors induces calpain-mediated PSD-95/Dlg/ZO-1 protein degradation and AMPA receptor down-regulation in cultured hippocampal slices. The Journal of Pharmacology and Experimental Therapeutics. 314: 16-26. PMID 15784649 DOI: 10.1124/Jpet.105.083873 |
0.543 |
|
2005 |
Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proceedings of the National Academy of Sciences of the United States of America. 102: 874-9. PMID 15647369 DOI: 10.1073/Pnas.0408891102 |
0.337 |
|
2005 |
Lu X, Barr AM, Bartfai T. Galanin receptors as novel drug targets for the treatment of depression and anxiety Drug Development Research. 65: 227-236. DOI: 10.1002/Ddr.20026 |
0.382 |
|
2004 |
Ceide SC, Trembleau L, Haberhauer G, Somogyi L, Lu X, Bartfai T, Rebek J. Synthesis of galmic: a nonpeptide galanin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America. 101: 16727-32. PMID 15557002 DOI: 10.1073/Pnas.0407543101 |
0.352 |
|
2004 |
Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Kröck L, Rebek J. Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proceedings of the National Academy of Sciences of the United States of America. 101: 10470-5. PMID 15240875 DOI: 10.1073/Pnas.0403802101 |
0.369 |
|
2004 |
Mazarati A, Lu X, Kilk K, Langel U, Wasterlain C, Bartfai T. Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus. The European Journal of Neuroscience. 19: 3235-44. PMID 15217380 DOI: 10.1111/J.0953-816X.2004.03449.X |
0.316 |
|
2001 |
Rong Y, Lu X, Bernard A, Khrestchatisky M, Baudry M. Tyrosine phosphorylation of ionotropic glutamate receptors by Fyn or Src differentially modulates their susceptibility to calpain and enhances their binding to spectrin and PSD-95. Journal of Neurochemistry. 79: 382-90. PMID 11677266 DOI: 10.1046/J.1471-4159.2001.00565.X |
0.518 |
|
2001 |
Lu X, Wyszynski M, Sheng M, Baudry M. Proteolysis of glutamate receptor-interacting protein by calpain in rat brain: implications for synaptic plasticity. Journal of Neurochemistry. 77: 1553-60. PMID 11413238 DOI: 10.1046/J.1471-4159.2001.00359.X |
0.518 |
|
2000 |
Lu X, Rong Y, Baudry M. Calpain-mediated degradation of PSD-95 in developing and adult rat brain. Neuroscience Letters. 286: 149-53. PMID 10825658 DOI: 10.1016/S0304-3940(00)01101-0 |
0.487 |
|
2000 |
Lu X, Rong Y, Bi R, Baudry M. Calpain-mediated truncation of rat brain AMPA receptors increases their Triton X-100 solubility. Brain Research. 863: 143-50. PMID 10773202 DOI: 10.1016/S0006-8993(00)02112-0 |
0.526 |
|
Show low-probability matches. |